UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
INTS holding history
Intensity Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INTS overviewAll 13F holders of INTSFull Q2 2026 holdings
- Shares (Q2 2026)
- 1
- Value
- $4
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $4 | <0.1% | −191−99.5% | Reduced | Holders |
| Q1 2026 | 192 | $1.13K | <0.1% | −25,205−99.2% | Reduced | Holders |
| Q4 2025 | 25,397 | $10.4K | <0.1% | −110,835−81.4% | Reduced | Holders |
| Q3 2025 | 136,232 | $33.1K | <0.1% | +126,998+1,375.3% | Added | Holders |
| Q2 2025 | 9,234 | $2.83K | <0.1% | +6,137+198.2% | Added | Holders |
| Q1 2025 | 3,097 | $6.10K | <0.1% | +76+2.5% | Added | Holders |
| Q4 2024 | 3,021 | $5.32K | <0.1% | −17,588−85.3% | Reduced | Holders |
| Q3 2024 | 20,609 | $78.7K | <0.1% | +17,293+521.5% | Added | Holders |
| Q2 2024 | 3,316 | $16.2K | <0.1% | +305+10.1% | Added | Holders |
| Q1 2024 | 3,011 | $15.7K | <0.1% | +2,511+502.2% | Added | Holders |
| Q4 2023 | 500 | $4.29K | <0.1% | +500 | New | Holders |